We studied 236 consecutive ambulatory patients (mean age = 65.5 years; 110 men) with treated EHT (mean systolic blood pressure = 134.3 mmHg, mean serum N-terminal pro-B-type natriuretic peptide = 86.6 pg/ml) for mean 65.6 months. Patients with a history of HF were excluded. Single and multiple variable analyses were performed in search of clinical correlates of elevated hs-TnT (?.003 ng/ml).
Serum concentration of hs-TnT was ?.003 ng/ml (mean = 0.008 ng/ml) in 184 patients. By single variable analysis, age, uric acid, log-transformed N-terminal pro-B-type natriuretic peptide, brachial-ankle pulse wave velocity, Cornell electrocardiographic (ECG) voltage, and number of antihypertensive medications were associated with log-transformed hs-TnT, while hemoglobin and estimated glomerular filtration rate (eGFR) were inversely correlated with log-transformed hs-TnT. By multivariate analysis, age, eGFR and Cornell voltage were independent correlates of log-transformed hs-TnT, even after adjustment for clinical backgrounds including known prognostic biomarkers of EHT.
hs-TnT was ?.003 ng/ml in 78 % of patients presenting with treated EHT and independently correlated with age, renal function, and ECG voltage of hypertrophy.